|
|
|
|
Vol. 14, Issue 7, 2655-2664, July 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


*Department of Experimental and Diagnostic
Medicine, Section of General Pathology, and Interdisciplinary Center for the
Study of Inflammation (ICSI), University of Ferrara, I-44100 Ferrara, Italy;
and
Abramson Family Cancer Research Institute,
BRB II/III, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Submitted April 22, 2002;
Revised January 27, 2003;
Accepted March 17, 2003
Monitoring Editor: Guido Guidotti
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Accruing evidence suggests that substantial amounts of ATP can accumulate
in the pericellular space under several physiological or pathological
conditions (Ferrari et al.,
1997
; Beigi et al.,
1999
; Schwiebert et
al., 2002
; Warny et
al., 2001
). This nucleotide, by acting at plasma membrane P2
receptors, triggers different cell responses, such as secretion, chemotaxis,
proliferation, transcription factor activation, or even cytotoxicity
(Di Virgilio et al.,
2001
). In addition, ATP can also be a powerful apoptotic agent via
activation of the purinergic P2X7 receptor, a plasma membrane
nucleotidegated ion channel endowed with the peculiar ability to generate a
nonselective pore upon sustained stimulation
(Zanovello et al.,
1990
; Zheng et al.,
1991
; Surprenant et
al., 1996
). The intracellular pathways responsible for
P2X7-dependent apoptosis are only partially known, although they
seem to largely coincide with those activated by other better-known apoptotic
receptors such as Fas and the type I TNF receptor (TNFRI). P2X7
induces a massive depletion of intracellular K+, caspase-3
activation, degradation of nuclear lamin, DNA fragmentation, nuclear
condensation, and apoptotic body formation
(Steinberg and Silverstein,
1987
; Ferrari et al.,
1999
; Morelli et al.,
2001
). In addition, a typical feature of ATP-stimulated cells is
the occurrence of a dramatic membrane blebbing
(MacKenzie et al.,
2001
). The biochemical basis of membrane blebbing has not been
studied in detail, nor has it been unequivocally shown to be solely dependent
on the activation of the P2X7 receptor/channel. In the present
work, we have investigated the kinetics and biochemical mechanisms of
ATP-induced bleb formation in a HEK293 cell clone stably expressing a GFP
(green fluorescent protein)-tagged version of the P2X7 receptor
(P2X7-HEK293). This cell line lacks endogenous P2X receptors and is
therefore a good model system to study responses due to stimulation of the
transduced P2X7 receptor.
Our data demonstrate that P2X7 expression is sufficient to cause membrane blebbing in response to ATP; furthermore, we show that bleb formation 1) is rapid, reversible and Ca2+ dependent, 2) is independent of caspase-3, 3) requires an intact cytoskeleton, and 4) is prevented by an inhibitor of ROCK.
Taken together, these data suggest that ROCK activation is a key step in the early membrane modifications triggered by the P2X7 receptor.
| MATERIALS AND METHODS |
|---|
|
|
|---|
ATP and UTP were used at a concentration of 3 and 1 mM, respectively, and were both from Roche Diagnostics (Mannheim, Germany). Oxidized ATP (oATP) was synthesized in our laboratory and used at the concentration of 300 µM. Cells were preincubated for 2 h with oATP, rinsed several times with saline solution, and exposed to the different stimuli. Hexokinase (Sigma) was used at the concentration of 100 µg/ml. Cells were preincubated for 45 min and kept in the continuous presence of hexokinase throughout the experiment. z-VAD fluoromethylketone (z-VAD-fmk; 100 µM; Bachem, Bubendorf, Switzerland) and cytochalasin B (10 µM; Sigma) were added to the cell monolayer 10 min before the addition of ATP. The ROCK inhibitor Y-27632 was purchased from Tocris Cookson Ltd. (Bristol, UK). The anti-Fas mAb was a kind gift of Professor Klaus Schulze-Osthoff (University of Munster, Germany) and was used at a concentration of 1 µg/ml.
Transfection of HEK293 Cells and Selection of Stable Clones
HEK293 wt cells were transfected with calcium phosphate. Briefly, the first
day, 2.5 x 106 HEK293 cells were plated in Petri dishes. The
second day, for each dish, 30 µg of plasmid DNA was resuspended in a total
volume of 450 µl TE (10 mM Tris, 1 mM EDTA, pH 8) and then 50 µl of a
2.5 M CaCl2 solution was added. This solution was added dropwise
under vortexing to a tube containing 500 µl of 2x HBS (280 mM NaCl,
50 mM HEPES, 1 mM Na2HPO4, pH 7.12, at 25°C). After
a 30-min incubation at room temperature, the DNA precipitate was added to the
dish dropwise. The third day medium was changed. The fourth day, G418, 0.8
mg/ml, was added to fresh medium to select transfected clones. After clone
selection, the selective medium contained G418, 0.2 mg/ml.
Transient transfection was performed using the same procedure directly on coverslips for 0.5 x 106 cells, 48 µg of plasmid DNA in a total volume of 90 µl TE, 10 µl of CaCl2 solution, and 100 µl of 2x HBS. The plasmid containing rat P2X7-GFP in pcDNA3 used for stable transfection was kindly provided by Dr. Annemarie Surprenant (University of Sheffield, UK).
Collection and Analysis of the GFP Images
Transfected cells seeded on coverslips were observed using a Nikon Eclipse
TE-300 fluorescence microscope (Nikon Co., Tokyo, Japan) equipped with a
thermostated chamber and the following filter set: excitation HQ480/40,
dichroic Q480LP, and emission HQ510LP. The microscope was also equipped with
the following devices to form a system for high-speed acquisition and
processing of fluorescent images: a computer-controlled light shutter, a
six-position filter wheel, a piezoelectric z-axis focus device, a
back-illuminated 1000x 800 CCD camera (Princeton Instruments, Princeton,
AZ), a computer equipped with Metamorph software (Universal Imaging
Corporation, Downingtown, PA) for image acquisition, 2-D and 3-D visualization
and analysis. All experiments were performed at 37°C in the standard
saline solution described in Cells, Solutions, and Reagents. Microscopic
observations were carried out with recently thawed P2X7-HEK293,
never exceeding the 10th in vitro passage. Recordings were performed with at
least 10 different recently thawed cell batches, and the effect of inhibitors
was consistently reproduced in three or more separate experiments. Criteria
for induction of blebbing were 1) that at least one bleb per cell was produced
within 12 min of ATP addition, 2) that within 35 min all cells
in the field were actively blebbing, and 3) that, unless ATP was removed, this
process continued as long as cells did not detach from the substrate. An
inhibitor was considered effective if it was able to fully block blebbing (no
blebs at any time points).
Rho Pull-down Assay
The pull-down assay was performed as described in Coleman et al.,
(2001
). Briefly, cells (5
x 1010) were plated in 10-cm Petri dishes, grown for 48 h,
and serum-starved for further 24 h. Lysis was performed in 50 mM Tris, pH 7.2,
500 mM NaCl (TBS), 1% (vol/vol) Triton X-100, 5 mM MgCl2, 1 mM DTT,
and protease inhibitors. An aliquot of cell lysates was used for determination
of protein concentration, whereas the remainder was spun at 10,000 x
g for 5 min. The supernatant was then mixed with 20 µg of
bacterially expressed GST-Rhotekin (murine amino acids 789) prebound to
75100 µl glutathione-Sepharose beads and incubated at 4°C with
tumbling for 30 min. Samples were spun, the supernatant was removed, and beads
were washed three times in TBS containing 1% (vol/vol) Triton X-100, 5 mM
MgCl2, and 1 mM DTT before mixing with Laemmli buffer and analysis
by Western blotting (see below).
Cell-permeable Tat-C3 Botulinum Toxin
The cell-permeable C3 toxin was prepared as described in Coleman et
al. (2001
). Briefly, the
C3 recombinant protein, modified to include the nucleotide sequence
5'-GGA GGA TAC GGC CGA AAG AAG CGA CAG CGA CGC CGT GGA GGA of the
thrombin cleavage site, was produced in E. coli BL21 and induced with
0.3 mM isopropyl-
-thiogalactopyranoside (IPTG) for 3 h at 32°C.
Cells were lysed in TBS containing 5 mM MgCl2, 1 mM DTT, and
protease inhibitors by quick freezing followed by sonication. After
centrifugation at 10,000 x g for 10 min at 4°C, the
supernatant was incubated with glutathione-Sepharose for 2 h at 4°C. The
beads were then washed with TBS plus 5 mM MgCl2 and 1 mM DTT. To
cleave Tat-C3, beads were incubated in TBS plus 1 mM MgCl2, 1 mM
CaCl2, 1 mM DTT, and 30 U of thrombin overnight at 4°C. The
supernatant was then removed and incubated with p-aminobenzamidine
beads for 1 h. Supernatants containing Tat-C3 were frozen and used at
0.51.0 µM in culture medium.
Immunoblotting
Cells were lysated in lysis buffer containing TBS Triton 0.1%, 1 mM
benzamidine, 1 mM phenylmethanesulfonyl fluoride (PMSF), 0.2 µg DNase, and
0.2 µg Rnase (only for ROCK I analysis, lysis buffer also contained 1 mM
diisopropylfluorophosphate [Fluka Chemie, Buchs, Switzerland], and cells were
preincubated in the presence of this inhibitor for 1 h before lysis). Proteins
were separated on 6% (ROCK I) or 14% (RhoA) SDS-polyacrylamide gel according
to Laemmli, blotted on nitrocellulose paper (Amersham Life Sciences, Cologno
Monzese, Italy), and hybridized with anti-ROCK I (clone 46; BD Transduction
Laboratories, Los Angeles, CA) or anti-RhoA (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA) mAbs.
| RESULTS |
|---|
|
|
|---|
(Zanovello
et al., 1990
|
|
Blebs originated as projections of the plasma membrane that surrounded an
optically empty cytoplasm apparently free of intracellular organelles. Cells
appear to undergo a "boiling process" that caused a continuous
formation and resorption of blebs of various sizes. The usual pattern included
formation of small size blebs during the early phases, followed by protrusion
of increasingly larger blebs often generated by fusion of smaller blebs. The
observation was continued for >20 min, and at the end of this time cells
started to detach from the substrate and disappear from the microscopic field.
Removal of ATP stopped bleb formation and allowed full recovery of cell shape
and volume (Figure 2, lower
panels), thus showing that the process was reversible. We compared blebbing in
HEK293 cells transfected with either the chimeric P2X7-GFP or
wtP2X7 and observed a longer lag in the beginning of blebbing in
the former cells, which, after this initial delay, proceeded on a similar time
scale in both transfectants. Smart et al.
(2002
) have recently published
a thorough analysis of the effect of GFP fusion at the N or C termini of
P2X7. They reported an approximately threefold decrease in
sensitivity to ATP with GFP fused at the P2X7 C termini, although
stimulation with a full dose of ATP (as that used in the present study) caused
maximal channel activation and pore formation. Among the few known blockers of
the P2X7 receptor, one of the most useful is oATP, a di-aldehyde
derivative that covalently binds and irreversibly blocks this receptor
(Murgia et al.,
1993
). Oxidized ATP could in principle also block other P2X
receptors, but this is not a drawback in P2X7-HEK293 because these
cells do not express other P2X subtypes.
Figure 3 shows that
preincubation with this blocker completely prevented ATP-induced bleb
formation throughout the observation time (45 min). After 2025 min,
some cell rounding became detectable but this did not lead to detachment or to
major morphological alterations for up to 45 min.
|
|
All cells express powerful ecto-ATPases/nucleotidases that rapidly degrade
added ATP to ADP and AMP, which in turn is hydrolized to adenosine by
5'-nucleotidase. Thus, it is possible that some of the effects of
extracellular ATP might be mediated by ATP degradation products such as ADP or
adenosine. To rule out participation of ATP degradation products, we added ATP
in the presence of hexokinase, an enzyme that generates glucose-6 phosphate
and ADP and accelerates the final degradation to AMP and adenosine
(Figure 4). Hexokinase
prevented blebbing throughout the incubation time, but for a brief outburst of
bleb formation soon after addition. As in the case of the experiments
performed in the presence of oATP, cells underwent some rounding. The HEK293
cell clone used in our laboratory endogenously express two P2Y subtypes:
P2Y1 and P2Y2 (our unpublished results, see also
Schachter et al.,
1997
). ADP is a much better agonist than ATP for P2Y1
(Ralevic and Burnstock, 1998
;
von Kugelgen and Wetter,
2000
); thus, we can exclude a main role of this receptor in
blebbing because in the presence of hexokinase large amounts of ADP are
formed, and yet the cells did not bleb. UTP and ATP are equipotent as agonists
of P2Y2. To test the possible involvement of P2Y2
receptors in blebbing, we incubated cells in the presence of 3 mM UTP. This
treatment caused some blebbing but only after >30 min of incubation (our
unpublished results). UTP-induced blebbing was fully abolished by hexokinase.
We did not further investigate UTP-induced bleb formation; however, these
latter observations show that it is a late event and suggest that it might be
secondary to P2Y-triggered release of ATP.
|
As a further control for the specificity of the effect of extracellular ATP, we used the parental wt HEK293 cells. To closely compare plasma membrane dynamics of P2X7less cells to that of P2X7-GFP transfectants, wt HEK293 cells were transfected with a SNAP-25GFPcontaining plasmid. SNAP-25 is a protein that localizes to the cytoplasmic side of the plasma membrane, thus allowing easy detection of cell shape changes and possible occurrence of bleb formation. Figure 5 shows that an incubation of cells lacking P2X7 with ATP for up to 20 min had no effect on cell morphology, nor did it induce bleb formation.
Formation of membrane blebs is dependent on contraction of the cytoskeleton; therefore it is expected to be inhibited by chelation of Ca2+ or administration of the cytoskeletal poison cytochalasin B. Figure 6 shows that in the absence of added Ca2+ and in the presence of EGTA (nominal extracellular free Ca2+ concentration <107 M) blebbing did not occur, although P2X7 is known to be fully active under these conditions. Instead, cells swelled and rounded, a process likely due to the massive influx of Na+, which is known to occur through P2X7 in the absence of external Ca2+. Thus, ATP-induced bleb formation requires a large and sustained increase in cytoplasmic Ca2+ due to influx across the plasma membrane. Bleb formation was also prevented by cell poisoning with cytochalasin, and as in the case of the experiments at low extracellular Ca2+, cells underwent a large increase in volume (our unpublished results).
|
Bleb formation is a complex event dependent on the stimulation of specific
intracellular pathways activated during apoptosis. It has been recently
reported that TNFRI and Fas-induced blebbing is mediated by caspase-3 and ROCK
I (Coleman et al.,
2001
; Sebbagh et al.,
2001
). Thus, we investigated whether these pathways were also
stimulated during P2X7-dependent bleb formation. First, we treated
P2X7-HEK293 cells with the wide range caspase blocker z-VAD-fmk
before their exposure to ATP. This treatment did not prevent or delay blebbing
(blebs were easily detected 1 min after the addition of ATP; our unpublished
results). We then tested the ROCK inhibitor Y-27632, which completely blocked
bleb formation (Figure 7). An
incidental observation was that in the presence of Y-27632,
P2X7-HEK293 cells lost their rounded morphology and reverted to the
usual spindle-like phenotype typical of wt HEK293 cells. An obvious
implication of the inhibitory effect of Y-27632 is that extracellular ATP
triggers ROCK activation via the P2X7 receptor, and ROCK in turn
mediates the cytoskeletal rearrangement responsible for membrane blebbing. To
test this hypothesis, we investigated cleavage of the ROCK I isoform in
P2X7-HEK293 cells. As a control, we tested the effect of an
anti-Fas mAb, a treatment shown previously to trigger ROCK I cleavage
(Figure 8).
|
|
The effect of Fas stimulation was tested in Jurkat as well as in P2X7-HEK293 cells. Fas activation lead to the formation of the cleaved 130-kDa active form of ROCK I, more extensively in Jurkat compared with P2X7-HEK293 cells. ATP treatment of P2X7-HEK293 cells caused accumulation of a 130-kDa band, and rather interestingly but in agreement with the experiments on ATP-induced bleb formation, this process was not inhibited by z-VAD-fmk. We assessed ROCK I proteolysis at various time points, starting 1 min after the addition of ATP. Even at this early time point the 130-kDa fragment was detectable (Figure 8B), suggesting that cleavage of ROCK I might be a very early event after ATP stimulation. ROCK I cleavage stimulated by ATP was z-VAD-fmk insensitive at all time points examined, whereas on the contrary it was z-VAD-sensitive when the stimulus was the anti-Fas antibody both in Jurkat (Figure 8A) and in HEK293 cells (Figure 8B).
Although clearly detectable, evidence of ROCK I cleavage does not rule out
the possibility that ROCK I stimulation also occurs by other more conventional
pathways, such as activation by Rho GTPases. To test this directly, we
performed a pull-down experiment (Figure
9), to assay the RhoA activation status in ATP-stimulated cells.
We found that in resting P2X7-HEK293 cells RhoA was already in a
partially activated state that was only very slightly increased by ATP
stimulation after 20 min of incubation. We were unable to detect significant
differences 1 min after ATP stimulation, when blebbing started. As a control,
we show that histamine caused a large RhoA activation. Then, we tested the
effect of the C3 botulinum toxin, a selective Rho ADP-ribosylating and
-inactivating agent. The toxin was rendered cell permeable by fusion to a
portion of the human immunodeficiency virus protein Tat.
Figure 10A shows that 500 or
1000 nM Tat-C3 caused a nearly complete ADP-ribosylation of RhoA, as indicated
by a MW shift. With 500 nM Tat-C3, ATP-induced blebbing was essentially
unimpaired (Figure 10B);
however, with 1 µM there was a substantial delay in blebbing that did not
start until after
20 min (Figure
10C), as if treatment with a supramaximal dose of toxin was
necessary to fully inhibit all residual RhoA-dependent activity. This suggests
that the Rho pathway may also play a role in P2X7-dependent ROCK
activation.
|
|
Finally, we checked whether P2X7 might drive ROCK I cleavage by
activating other intracellular proteases. Although calpains have been
implicated in the control of cytoskeletal dynamics and apoptosis
(Chan and Mattson, 1999
), we
found that specific calpain inhibitors (Calpain Inhibitor I, ALLN, and Calpain
Inhibitor II, ALLM), were unable to prevent ATP-induced ROCK I cleavage and
activation (our unpublished results).
| DISCUSSION |
|---|
|
|
|---|
The responses elicited by extracellular ATP depend in the first place on
the given P2 receptor subtype(s) expressed by the responding cell and the
intensity of stimulation. Among the many different responses produced by ATP
stimulation, cytotoxicity is one of the most intriguing and potentially most
interesting. This phenomenon was initially described by Mirabelli and
coworkers (1986
) and later
extensively investigated in several laboratories, including our own
(Di Virgilio et al.,
1989
; Filippini et
al., 1990
; Zanovello
et al., 1990
; Zheng
et al., 1991
). Prolonged incubation in the presence of
extracellular ATP can cause cell death by either necrosis or apoptosis.
Whether one or the other pathway predominates depends on the cell type and the
dose and length of exposure to the nucleotide. There are few doubts that the
principal (and according to some investigators the only) P2 receptor capable
of triggering cell death is P2X7, a ligand-gated receptor channel,
permeable to mono- and di-valent cations, whose only physiological ligand is
ATP. This receptor is a homo-oligomer made of subunits (probably three or six)
composed of 595 amino acids each
(Surprenant et al.,
1996
; Kim et al.,
2001b
). In the presence of low ATP concentrations or in response
to a single pulse of ATP, P2X7 behaves as a conventional
cation-selective channel. However, when exposed to high ATP concentrations or
to repeated pulses of the agonist, it undergoes a channel to pore transition
that allows hydrophilic solutes of molecular mass up to 900 Da through the
plasma membrane (Di Virgilio,
1995
; Surprenant et
al., 1996
). Although P2X7 is not the only P2X
receptor for which such a peculiar behavior has been described
(Khakh et al., 1999
;
Virginio et al.,
1999
), it is the receptor for which the channel/pore transition
has been most extensively and reproducibly documented. The physiological
meaning of this phenomenon is not understood, although some intriguing
hypotheses have been forwarded (Di Virgilio,
1995
,
2000
;
Di Virgilio et al.,
2001
). Whatever the real physiological function of the
P2X7 pore might be, there is no doubt that such a lesion is lethal
if it remains patent for any extended time (>1015 min in most cell
types).
P2X7-mediated cell death occurs either via necrosis or
apoptosis. We have observed that cells expressing this receptor to a high
level are more prone to undergo fast necrotic death, probably because the
rapid upset of intracellular ion homeostasis prevents the initiation of the
complex chain of events necessary for apoptosis
(Zanovello et al.,
1990
). On the other hand, cells with a lower expression of
P2X7 or where this receptor forms a smaller sized pore, such as the
lymphocytes, are more likely to die by apoptosis. Although seldom acknowledged
as a proapoptotic receptor, P2X7 triggers many of the changes
typical of this process: membrane blebbing, phosphatidylserine exposure, cell
shrinkage, activation of caspases 1, 3, and 8, cleavage of the caspase
substrates PARP and lamin B, chromatin condensation, DNA fragmentation, and
apoptotic body formation (Zanovello et
al., 1990
; Zheng et
al., 1991
; Ferrari et
al., 1999
). Although originally bleb formation and
phosphatidylserine exposure were regarded as unequivocal indications of
apoptosis, it is now increasingly appreciated that these changes are not
necessarily followed by cell death (see
MacKenzie et al.,
2001
). Our data also support this view because, provided ATP was
removed within 1520 min, blebbing was reversible. However, a more
prolonged exposure to ATP almost invariably committed P2X7-HEK293
cells to death, in agreement with MacKenzie et al.
(2001
).
The seemingly simple process of bleb formation is powered by the
contractile forces generated by the acto-myosin cytoskeleton through the
modulation of a complex array of intracellular signaling molecules that
modulate MLC phosphorylation, control myosin ATPase activity, bridge the
cytoskeleton with the plasma membrane, and stabilize filamentous actin.
Cytoskeletal contractility is critically dependent on the activity of the Rho
GTPases, which in their GTP-bound form stimulate the activity of the two ROCK
isoforms I and II. Recent data show that ROCK I, but not Rho, activity is
necessary for TNF-
stimulated cells to undergo the full sequence
of morphological alterations of apoptosis, from membrane blebbing to apoptotic
body formation (Coleman et al.,
2001
; Sebbagh et al.,
2001
).
Extracellular ATP triggers via P2X7 dramatic changes in cell
shape and volume that are commonly thought to be the mere consequence of the
ion unbalance caused by large pore formation. A large
Ca2+ influx is indeed necessary because our study shows
that in the absence of extracellular Ca2+ ATP-induced
bleb formation is fully inhibited. A functioning cytoskeleton is also
obviously required, because the powerful cytoskeletal poison cytochalasin B
blocks blebbing. However, our data show that a large
Ca2+ influx and a functioning cytoskeleton are not by
themselves sufficient for bleb formation; rather, a complex chain of events
downstream of P2X7 is very rapidly triggered and is critically
required for the full-blown pattern of morphological changes. Like the process
triggered by the TNF-
receptor, by C2-ceramide, or by cycloheximide,
ATP-induced membrane blebbing also is critically dependent on ROCK I activity.
However, at variance with these stimuli and despite the fact that
P2X7 has been shown to activate caspases
(Ferrari et al.,
1999
), ATP-induced ROCK I cleavage and membrane blebbing are
independent of caspase-3 activation. The identity of the pathway coupling
P2X7 to ROCK I is therefore an open question.
We think it likely that P2X7 causes ROCK activation via a
multiplicity of convergent pathways, some leading to direct ROCK I cleavage
and activation, and therefore proapoptotic, and others to Rho-mediated ROCK I
stimulation, and therefore nonapoptotic. Generation of a constitutive ROCK I
kinase via cleavage of the C-terminal portion with ATP doses and kinetics
compatible with blebbing is shown by Western blot analysis, but the identity
of the protease responsible for the ATP-induced ROCK I cleavage is as yet
unknown. We hypothesized that calpain might be involved, but inhibitors of
this protease were unable to prevent the ATP effect. On the other hand, a role
for Rho is supported by the delayed blebbing caused by treatment of
P2X7-HEK293 cells with a supramaximal dose of Tat-C3 toxin and by
reversibility of bleb formation when ATP is removed within 1520 min of
addition. However, two observations are puzzling: first, blebbing was
unaffected by a low Tat-C3 dose (500 nM), which was nevertheless apparently
able to modify all available RhoA; second, in the pull-down experiment we
observed a minor increase in GTP-RhoA only at a late time point (20 min), when
blebbing was well underway. We should also consider other possible pathways.
For example, it might be that the P2X7 is indirectly coupled to
ROCK kinases via the Ca2+ increase (or the K+
decrease; Sanz and Di Virgilio,
2000
), or via one of the proteins known to coassemble with this
receptor (Kim et al.,
2001a
). Indirect coupling could also occur through the release of
a diffusible soluble messenger generated at the plasma membrane, e.g.,
arachidonic acid, known to bind the C-terminal regulatory domain and to
activate the ROCK I kinase (Feng et
al., 1999
). Therefore, although our data strongly point to
the involvement of ROCK I, the underlying mechanism of activation needs
further investigation.
In our hands, sustained activation of P2X7 beyond 2030
min leads to P2X7-HEK293 cell detachment from the substrate and
death, not unlike other cell types expressing high P2X7 levels.
MacKenzie et al.
(2001
) reported that
P2X7-HEK293 stimulated with benzoyl ATP, a more potent and
selective P2X7 agonist, were still alive after 30 min, significant
cell loss being detectable only after 6 h. We did observe that after several
in vitro passages P2X7-HEK293 cells became increasingly resistant
to ATP (for example, they did not detach but rather became more adherent), but
we did not perform a thorough characterization of phenotypic changes shown by
P2X7-HEK293 after prolonged culture.
In conclusion, we have described the dramatic plasma membrane dynamics caused by stimulation of the P2X7 ATP receptor and have provided clues as to the intracellular mechanisms involved. Future experiments will hopefully disclose the protease(s) responsible for ROCK I cleavage and how it is coupled to P2X7.
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| Footnotes |
|---|
Abbreviations used: GFP, green fluorescent protein; MLC, myosin light chain; oATP, oxidized ATP; TNFRI, type I TNF receptor.
Online version of this article contains video material. Online version is
available at
www.molbiolcell.org. ![]()
Corresponding author. E-mail address:
fdv{at}unife.it.
| REFERENCES |
|---|
|
|
|---|
Beigi, R., Kobatake, E., Aizawa, M., and Dubyak, G.R. (1999). Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am. J. Physiol. 276, C267C278.
Chan, S.L., and Mattson, M.P. (1999). Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58, 167190.[CrossRef][Medline]
Chizh, B.A., and Illes, P. (2001). P2X receptors and
nociception. Pharmacol. Rev.
53,
553568.
Chvatchko, Y., Valera, S., Aubry, J.P., Renno, T., Buell, G., and Bonnefoy, J.Y. (1996). The involvement of an ATP-gated ion channel, P2X1 in thymocyte apoptosis. Immunity 5, 275283.[CrossRef][Medline]
Coleman, M.L., Sahai, E.A., Yeo, M., Bosch, M., Dewar, A., and Olson, M.F. (2001). Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3, 339346.[CrossRef][Medline]
Di Virgilio, F. (1995). The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16, 524528.[CrossRef][Medline]
Di Virgilio, F. (2000). Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP. J. Autonom. Nerv. Syst. 81, 5963.[CrossRef][Medline]
Di Virgilio, F., Bronte, V., Collavo, D., and Zanovello, P. (1989). Responses of mouse lymphocytes to extracellular adenosine 5'-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effect of ATP. J. Immunol. 143, 19551960.[Abstract]
Di Virgilio, F., Chiozzi, P., Falzoni, S., Ferrari, D., Sanz, J.M., Venketaraman, V., and Baricordi, O.R. (1998). Cytolytic P2X purinoceptors. Cell Death Differ. 5, 191199.[CrossRef][Medline]
Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J.M.,
Morelli, A., Torboli, M., Bolognesi, G., and Baricordi, O.R.
(2001). Nucleotide receptors: an emerging family of regulatory
molecules. Blood 97,
587600.
Feng, J. et al. (1999). Rho-associated kinase
of chicken gizzard smooth muscle. J. Biol. Chem.
274,
37443752.
Ferrari, D., Chiozzi, P., Falzoni, S., Hanau, S., and Di Virgilio,
F. (1997). Purinergic modulation of interleukin-1
release
from microglial cells stimulated with bacterial endotoxin. J. Exp.
Med. 185,
579582.
Ferrari, D., Los, M., Bauer, M.K.A., Vandenabeele, P., Wesselborg, S., and Schulze-Osthoff, K. (1999). P2Z purinoceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett. 447, 7175.[CrossRef][Medline]
Ferri, K.F., and Kroemer, G. (2001). Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3, E255E263.[CrossRef][Medline]
Filippini, A., Taffs, R.E., Agui, T., and Sitkovsky, M.V.
(1990). Ecto-ATPase activity in cytolytic T lymphocytes.
Protection from the cytotoxic effects of extracellular ATP. J. Biol.
Chem. 265,
334340.
Fukata, Y., Amano, M., and Kaibuchi, K. (2001). Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non muscle cells. Trends Pharmacol. Sci. 22, 3239.[CrossRef][Medline]
Khakh, B., Bao, X., Labarca, C., and Lester, H. (1999). Neuronal P2X receptor-transmitter-gated cation channels change their ion selectivity in seconds. Nature Neurosci. 2, 322330.[CrossRef][Medline]
Kim, M., Jiang, L.H., Wilson, H.L., North, R.A., and Surprenant, A. (2001a). Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 20, 63476358.[CrossRef][Medline]
Kim, M., Spelta, V., Sim, J., North, R.A., and Surprenant, A.
(2001b). Differential assembly of rat purinergic P2X7
receptor in immune cell of the brain and periphery. J. Biol.
Chem. 276,
2326223267.
Kimura, K. et al. (1996). Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273, 245248.[Abstract]
Inoue, C.N., Woo, J.S., Schwiebert, E.M., Morita, T., Hanaoka, K., Guggino, S.E., and Guggino, W.B. (1997). Role of purinergic receptors in chloride secretion in Caco-2 cells. Am. J. Physiol. 272, C1862C1870.
MacKenzie, A., Wilson, H.L., Kiss-Toth, E., Dower, S.K., North,
R.A., and Surprenant, A. (2001). Rapid secretion of
interleukin-1
by microvesicle shedding. Immunity,
8,
825835.
Mirabelli, F., Bellomo, G., Nicotera, P., Moore, M., and Orrenius, S. (1986). Ca2+ homeostasis and cytotoxicity in isolated hepatocytes: studies with extracellular adenosine 5'-triphosphate. J. Biochem. Toxicol. 1, 2939.[CrossRef][Medline]
Morelli, A., Ferrari, D., Bolognesi, G., Rizzuto, R., and Di Virgilio, F. (2001). Proapoptotic plasma membrane pore: P2X7 receptor. Drug Dev. Res. 52, 571578.[CrossRef]
Murgia, M., Hanau, S., Pizzo, P., Rippa, M., and Di Virgilio, F.
(1993). Oxidized ATP. An irreversible inhibitor of the macrophage
purinergic P2Z receptor. J. Biol. Chem.
268,
81998203.
North, R.A. (2002). The molecular physiology of P2X
receptors. Physiol. Rev. 82,
10131067.
Oshimi, Y., Miyazaki, S., and Oda, S. (1999). ATP-induced Ca2+ response mediated by P2U and P2Y purinoceptors in human macrophages: signalling from dying cells. Immunology 98, 220227.[CrossRef][Medline]
Ralevic, V., and Burnstock, G. (1998). Receptors for
purines and pyrimidines. Pharmacol. Rev.
50,
413492.
Sanz, J.M., and Di Virgilio, F. (2000). Kinetics and
mechanism of ATP-dependent IL-1
release from microglial cells. J.
Immunol. 164,
48934898.
Schachter, J.B., Sromek, S.M., Nicholas, R.A., and Harden, T.K. (1997). HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors. Neuropharmacology 36, 11811187.[CrossRef][Medline]
Schwiebert, L.M., Rice, W.C., Kudlow, B.A., Taylor, A.L., and Schwiebert, E.M. (2002). Extracellular ATP signalling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. Am. J. Physiol. 282, C289C301.
Sebbagh, M., Renvoizè, C., Hamelin, J., Richè, N., Bertoglio, J., and Breard, J. (2001). Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol. 3, 346352.[CrossRef][Medline]
Smart, M.L., Panchal, R.G., Bowser, D.N., Williams, D.A., and Petrou, S. (2002). Pore formation is not associated with macroscopic redistribution of P2X7 receptors. Am. J. Physiol. 283, C77C84.
Steinberg, T.H., and Silverstein, S.C. (1987).
Extracellular ATP4 promotes cation fluxes in the
J774 mouse macrophage cell line. J. Biol. Chem.
262,
31183122.
Surprenant, A., Rassendren, F., Kawashima, E., North, R.A., and Buell, G. (1996). The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272, 735738.[Abstract]
Torgerson, R.R., and McNiven, M.A. (1998). The actin-myosin cytoskeleton mediates reversible agonist-induced membrane blebbing. J. Cell Sci. 111, 29112922.[Abstract]
Virginio, C., MacKenzie, A., Rassendren, F.A., North, R.A., and Surprenant, A. (1999). Pore dilation of neuronal P2X receptor channels. Nat. Neurosci. 2, 315321.[CrossRef][Medline]
Vlaskovska, M., Kasakov, L., Rong, W., Bodin, P., Bardini, M.,
Cockaine, D.A., Ford, A.P.D.W., and Burnstock, G. (2001).
P2X3 knock-out mice reveal a major sensory role for
urothelially-released ATP. J. Neurosci.
21,
56705677.
von Kugelgen, I., and Wetter, A. (2000). Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 362, 310323.[CrossRef][Medline]
Warny, M., Aboudola, S., Robson, S.C., Sevigny, J., Communi, D.,
Soltoff, S.P., and Kelly, C.P. (2001). P2Y6 nucleotide
receptor mediates monocyte IL-8 production in response to UDP or
lipopolysaccharide. J. Biol. Chem.
276,
2605126056.
Yu, S.P., Canzoniero, L.M., and Choi, D.W. (2001). Ion homeostasis and apoptosis. Curr. Opin. Cell Biol. 13, 405411.[CrossRef][Medline]
Zanovello, P., Bronte, V., Rosato, A., Pizzo, P., and Di Virgilio, F. (1990). Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. J. Immunol. 145, 15451550.[Abstract]
Zheng, L.M., Zychlinsky, A., Liu, C-C., Ojcius, D.M., and Young,
J.D-E. (1991). Extracellular ATP as a trigger for apoptosis or
programmed cell death. J. Cell Biol.
112,
279288.
Zimmermann, H. (2000). Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedberg's Arch. Pharmacol. 362, 299309.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
X. Liu, A. Surprenant, H.-J. Mao, S. Roger, R. Xia, H. Bradley, and L.-H. Jiang Identification of Key Residues Coordinating Functional Inhibition of P2X7 Receptors by Zinc and Copper Mol. Pharmacol., January 1, 2008; 73(1): 252 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tournaviti, S. Hannemann, S. Terjung, T. M. Kitzing, C. Stegmayer, J. Ritzerfeld, P. Walther, R. Grosse, W. Nickel, and O. T. Fackler SH4-domain-induced plasma membrane dynamization promotes bleb-associated cell motility J. Cell Sci., November 1, 2007; 120(21): 3820 - 3829. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pizzirani, D. Ferrari, P. Chiozzi, E. Adinolfi, D. Sandona, E. Savaglio, and F. Di Virgilio Stimulation of P2 receptors causes release of IL-1{beta}-loaded microvesicles from human dendritic cells Blood, May 1, 2007; 109(9): 3856 - 3864. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Panupinthu, L. Zhao, F. Possmayer, H. Z. Ke, S. M. Sims, and S. J. Dixon P2X7 Nucleotide Receptors Mediate Blebbing in Osteoblasts through a Pathway Involving Lysophosphatidic Acid J. Biol. Chem., February 2, 2007; 282(5): 3403 - 3412. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Young, P. Pelegrin, and A. Surprenant Amino Acid Residues in the P2X7 Receptor that Mediate Differential Sensitivity to ATP and BzATP Mol. Pharmacol., January 1, 2007; 71(1): 92 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Olteanu, M. B. Hovater, and E. M. Schwiebert Intraluminal autocrine purinergic signaling within cysts: implications for the progression of diseases that involve encapsulated cyst formation Am J Physiol Renal Physiol, January 1, 2007; 292(1): F11 - F14. [Full Text] [PDF] |
||||
![]() |
I. Lemaire, S. Falzoni, N. Leduc, B. Zhang, P. Pellegatti, E. Adinolfi, P. Chiozzi, and F. Di Virgilio Involvement of the Purinergic P2X7 Receptor in the Formation of Multinucleated Giant Cells J. Immunol., November 15, 2006; 177(10): 7257 - 7265. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Marin-Castano, G. E. Striker, O. Alcazar, P. Catanuto, D. G. Espinosa-Heidmann, and S. W. Cousins Repetitive Nonlethal Oxidant Injury to Retinal Pigment Epithelium Decreased Extracellular Matrix Turnover In Vitro and Induced Sub-RPE Deposits In Vivo. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4098 - 4112. [Abstract] [Full Text] [PDF] |
||||
![]() |
|